The abstract is read at the publisher; the summary is JClub's.
HLA-DRB1*04:01 is strongly associated with self-reported cefaclor adverse-reaction labels in 70,724 NMDP donors, with OR = 3.74 (p = 5.10E-28).
- Why it matters: Many common conditions are underrepresented in EHR, and prior HLA studies often relied on imputed microarray genotypes, limiting discovery of novel, clinically relevant associations.
- What they did: A phenome-wide association study tested over 290 conditions using high-resolution HLA-A, HLA-B, HLA-C, HLA-DRB1, and HLA-DQB1 genotypes, with logistic regression adjusted for sex and age after ancestry stratification.
- The result: The cefaclor association remained significant after excluding people reporting multiple drug hypersensitivities (OR = 3.13, p = 5.60E-15), and co-folding suggested a cefaclor interaction with the HLA-DRB1*04:01 P4 pocket.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.